RA
| |
Rosalind Advisors, Inc.13F | |
Rosalind Advisors, Inc. | |
Last update 2024-07-12 | 40 Stocks (5 new) |
Value $130.00 Mil | Turnover 33 % |
Portfolio Report |
Rosalind Advisors, Inc. Top Holdings of 2024-06-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DCTH | Delcath Systems Inc | 2,650,389 | 15528.630 | +155.13% | 11.950 | +7.27% | 9.540 | +36.66% | +173.32% | 318.370 | Medical Devices & Instruments | |
MYO | Myomo Inc | 2,664,999 | 8554.650 | +8.88% | 6.580 | +0.54% | 9.250 | -33.75% | -25.55% | 112.742 | Medical Devices & Instruments | |
MDWD | MediWound Ltd | 513,490 | 7969.370 | +5.66% | 6.130 | +0.33% | 5.530 | -10.32% | +69.22% | 185.634 | Biotechnology | |
OPTN | OptiNose Inc | 7,547,148 | 7849.030 | +66.18% | 6.040 | +2.41% | 6.680 | -24.00% | -38.73% | 119.174 | Drug Manufacturers | |
ABEO | Abeona Therapeutics Inc | 1,750,000 | 7420.000 | New Holding | 5.710 | +5.71% | 4.270 | +31.40% | +31.14% | 284.576 | Biotechnology | |
XERS | Xeris Biopharma Holdings Inc | 3,120,170 | 7020.380 | +10.64% | 5.400 | +0.52% | 2.100 | +23.27% | +28.51% | 449.976 | Biotechnology | |
CLRB | Cellectar Biosciences Inc | 2,705,616 | 6764.040 | +335.35% | 5.200 | +4.01% | 7.550 | -29.80% | -23.47% | 76.000 | Biotechnology | |
NSPR | InspireMD Inc | 2,513,641 | 6272.290 | +266.39% | 4.830 | +3.51% | 9.960 | +3.22% | -11.39% | 64.010 | Medical Devices & Instruments | |
CYBN | Cybin Inc | 507,590 | 5230.300 | +38.25% | 4.020 | +1.11% | 2.540 | +5.02% | -27.02% | 224.707 | Biotechnology | |
OCUL | Ocular Therapeutix Inc | 750,000 | 5130.000 | New Holding | 3.950 | +3.95% | 0.480 | +43.77% | +153.36% | 1761.915 | Biotechnology |
Rosalind Advisors, Inc.'s Historical Top Holdings Breakdowns
Rosalind Advisors, Inc.'s Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
DCTH | Delcath Systems Inc | 2024-06-30 | Add | +7.27% | 4.48 ($6.34) 8.37 | $11.37 | 79.34% | Add 155.13% | 2,650,389 | 1,611,561 | |
ABEO | Abeona Therapeutics Inc | 2024-06-30 | New Buy | +5.71% | 3.17 ($5.1) 8.05 | $6.57 | 28.82% | New holding | 1,750,000 | 1,750,000 | |
CLRB | Cellectar Biosciences Inc | 2024-06-30 | Add | +4.01% | 2.33 ($3.2) 3.99 | $2.12 | -33.75% | Add 335.35% | 2,705,616 | 2,084,138 | |
OCUL | Ocular Therapeutix Inc | 2024-06-30 | New Buy | +3.95% | 4.2 ($6.17) 8.69 | $11.30 | 83.14% | New holding | 750,000 | 750,000 | |
NSPR | InspireMD Inc | 2024-06-30 | Add | +3.51% | 1.85 ($2.34) 2.75 | $2.49 | 6.41% | Add 266.39% | 2,513,641 | 1,827,579 | |
OPTN | OptiNose Inc | 2024-06-30 | Add | +2.41% | 0.82 ($1.12) 1.44 | $0.79 | -29.43% | Add 66.18% | 7,547,148 | 3,005,659 | |
CARA | Cara Therapeutics Inc | 2024-06-30 | Sold Out | -1.32% | 0.24 ($0.66) 0.92 | $0.27 | -59.24% | Sold Out | 0 | -1,548,893 | |
VERU | Veru Inc | 2024-06-30 | Reduce | -1.18% | 0.76 ($1.16) 1.79 | $0.92 | -20.69% | Reduce -40.09% | 2,696,003 | -1,803,997 | |
CYBN | Cybin Inc | 2024-06-30 | Add | +1.11% | 10.03 ($13.09) 17.6 | $11.37 | -13.14% | Add 38.25% | 507,590 | 5,340,000 | |
TRVI | Trevi Therapeutics Inc | 2024-06-30 | Add | +1.07% | 2.44 ($2.78) 3.36 | $3.23 | 16.19% | Add 50.28% | 1,391,577 | 465,561 |
Rosalind Advisors, Inc. Total Holding History ($B)
Rosalind Advisors, Inc.'s Asset Allocation
Rosalind Advisors, Inc. Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Rosalind Advisors, Inc.'s Hypothetical Growth since 2024-06-30
Rosalind Advisors, Inc.'s Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Rosalind Advisors, Inc.'s Holdings Heat Map
Size field:
Rosalind Advisors, Inc.'s Holdings Bubble Chart
Rosalind Advisors, Inc. News
- 1